ORIGIN LIFE SCIENCES, INC.

Profile

Company Names

ORIGIN LIFE SCIENCES, INC.
ORIGIN, INC.
ADVANCED PLASMA THERAPIES, INC.

Addresses

2 RESEARCH WAY, THIRD FLOOR, PRINCETON, NJ 08540

1 MONROE AVENUE, LAWRENCEVILLE, NJ 08648

Phone Numbers

(609)250-6000
609-250-6000
845-494-5049

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$3,042,700.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-08-18 
$51,000.00 
$5,000,000.00 
$4,949,000.00 
Equity 
4
2023-05-30 
$659,600.00 
$850,000.00 
$190,400.00 
Equity 
3
2022-06-30 
$500,000.00 
$5,000,000.00 
$4,500,000.00 
Equity 
2
2017-01-06 
$1,332,100.00 
$22,500,000.00 
$21,167,900.00 
Equity 
1
2013-03-22 
$500,000.00 
$2,500,000.00 
$2,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ISSAC 
 
ANTHONY III 
EXECUTIVE OFFICER
ADVANCED PLASMA THERAPIES, INC.
ANTHONY 
 
BRAMPTON 
DIRECTOR
ABZENA PLC   |  ORIGIN LIFE SCIENCES, INC.
TONY 
 
BRAMPTON 
DIRECTOR
ORIGIN, INC.
DAVID 
 
DANTZKER 
EXECUTIVE OFFICER, DIRECTOR
NOVARAY MEDICAL, INC.   |  OLIGOMERIX, INC.   |  ORIGIN, INC.   |  ORIGIN LIFE SCIENCES, INC.
DAVID 
 
DANTZKER, MD 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PLASMA THERAPIES, INC.   |  ORIGIN, INC.
ALEX 
 
DOLGOPOLSKY, MD 
EXECUTIVE OFFICER
ADVANCED PLASMA THERAPIES, INC.
ALEX 
 
DOLGOPOLSKY, PHD 
EXECUTIVE OFFICER
ORIGIN, INC.
JOHN 
 
FERNANDES 
EXECUTIVE OFFICER
ORIGIN LIFE SCIENCES, INC.
JOHNNY 
 
FERNANDES 
EXECUTIVE OFFICER
ORIGIN, INC.
BETSY 
 
HANNA 
EXECUTIVE OFFICER
ORIGIN, INC.
JEROME 
BODA 
KORTEN 
DIRECTOR
ORIGIN LIFE SCIENCES, INC.
VIC 
 
MICATI 
DIRECTOR
ORIGIN, INC.
VICTOR 
 
MICATI 
DIRECTOR
OLIGOMERIX, INC.   |  ORIGIN LIFE SCIENCES, INC.
HOWARD 
 
NELSON 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PLASMA THERAPIES, INC.   |  ORIGIN, INC.
MICHAEL 
 
POHL 
EXECUTIVE OFFICER
ADVANCED PLASMA THERAPIES, INC.
MIKE 
 
POHL 
EXECUTIVE OFFICER
ORIGIN, INC.
MICHAEL 
DAVID 
PRESTON 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PLASMA THERAPIES, INC.   |  ORIGIN, INC.   |  ORIGIN LIFE SCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-17
D
Link
BIOTECHNOLOGY 
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845] 
DECLINE TO DISCLOSE 
Equity 
2023-08-18 
2023-06-22
D/A
Link
BIOTECHNOLOGY 
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845] 
DECLINE TO DISCLOSE 
Equity 
2023-05-30 
2023-06-01
D
Link
BIOTECHNOLOGY 
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845] 
DECLINE TO DISCLOSE 
Equity 
2023-05-30 
2022-09-07
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2022-06-30 
2017-05-15
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2017-01-06 
2013-04-08
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-03-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BOUSTEAD SECURITIES, LLC
141391
NONE
NONE
NONE
NONE